Aker Biomarine Asa · OSL:AKBM

Aker Biomarine Asa — DNB Nordic TMT & Consumer Conference 2021

17 slides from Aker Biomarine Asa's conference presentation, Sep 2, 2021

  1. Slide 1: Presentation at the DNB Nordic TMT & Consumer Conference

    Presentation at the DNB Nordic TMT & Consumer Conference 2 September 2021 Q3 2020 PRESENTATION Matts Johansen, CEO Katrine Klaveness, CFO 30 OCTOBER 2020 1

  2. Slide 2: Important Notice

    Important Notice This presentation has been prepared by Aker BioMarine ASA (the "Company"). The presentation does not constitute or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquire, any securities of the Company or a

  3. Slide 3: Aker BioMarine in a nutshell

    Aker BioMarine in a nutshell #1 246 289 154 125 2017 2018 2019 2020 Global krill harvester and High growth top line Best-in-class human, aqua, krill oil producer trajectory pet ingredients Vertically integrated business Sustainability at the High growth branded and model core private label supplemen

  4. Slide 4: Vertically integrated business model enables significant scale and flexibility

    Vertically integrated business model enables significant scale and flexibility Harvesting Ingredient production R&D Krill oil production Sales & marketing Distribution & brands ~70% ofkrillglobal catch 30% CO emissions reduction in 2 ~160 published studies >80% ofoil global krill production ~65 Coun

  5. Slide 5: History of strong top-line and earnings growth

    History of strong top-line and earnings growth Top-line evolution Profitability evolution Revenue Adjusted EBITDA and % margin (USDm) +2.3x (USDm) +4.3x 289 27.1% 25.6% 246 78 21.5% 154 14.1% 53 125 39 18 2017 2018 2019 2020 2017 2018 2019 2020 Geographic breakdown of revenue Product breakdown of re

  6. Slide 6: Five value creation pillars driving the company's MUSD 200 EBITDA aspiration

    Five value creation pillars driving the company's MUSD 200 EBITDA aspiration Human & Aqua Building branded Innovation-led Scale ingredients growth capabilities category extension Sustainable products and solutions 6

  7. Slide 7: Scale provides operational leverage and margin improvement potential

    Scale provides operational leverage and margin improvement potential Aker BioMarine costbase Scale example: Onshore volumes & unit cost USD/kg Variable Fixed cost 30% cost 70% MT 2016 2017 2018 2019 2020 2021E 7

  8. Slide 8: Well positioned with attractive value proposition in segments with strong underlying growth

    Well positioned with attractive value proposition in segments with strong underlying growth Aquaculture ingredients Human Nutrition ingredients Pet Food ingredients Share of 2020 revenue 47% Share of 2020 revenue 51% Share of 2020 revenue 2% Krill drives significant faster growth Krill is 2x more ef

  9. Slide 9: Established significant expertise in both private label and own branded consumer health and nutritional products

    Established significant expertise in both private label and own branded consumer health and nutritional products Private label offering Brand offering Revenue breakdown by customer Current retailers 2020 9

  10. Slide 10: New product launches with corresponding margin potential targeting significant margin uplift

    New product launches with corresponding margin potential targeting significant margin uplift Aqua feed Pet food Protein powder Krill oil Lysoveta Brands ingredients ingredients ingredients supplement ingredients 10

  11. Slide 11: Sustainability leadership, providing solutions for customers current and future sustainability challenges

    Sustainability leadership, providing solutions for customers current and future sustainability challenges NUTRITION, 2030 GOALS HEALTH & ACTION ON 2030 GOALS WELLBEING CLIMATE 1 billion extra servings CHANGE 50% reduction annually of carbon intensity RESPONSIBLE Net zero by 2050 SUSTAINABLE CONSUMPT

  12. Slide 12: Financials in Q2 2021 versus Q2 2020

    Financials in Q2 2021 versus Q2 2020 REVENUE ADJUSTED EBITDA1 ADJUSTED EBITDA MARGIN NET INTEREST-BEARING DEBT USDm USDm % USDm +3% +10% 26% -22% 72 74 26% 397 24% 19 18 311 Q2 2020 Q2 2021 Q2 2020 Q2 2021 Q2 2020 Q2 2021 Q2 2020 Q2 2021 1) Aker BioMarine evaluates the performance based on Adjusted

  13. Slide 13: Ingredients segment performance

    Ingredients segment performance REVENUE ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN USDm USDm 56 80% 23 25 51 50 70% 46 18 20 60% 17 16 50% 15 30 40% 45% 40% 10 30% 32% 7 31% 20% 24% 5 10% 0% - Q2 2020 Q3 2020 Q4 2020 Q1 2021 Q2 2021 Q2 2020 Q3 2020 Q4 2020 Q1 2021 Q2 2021 ▪ Qrill category sales incr

  14. Slide 14: Brands segment performance

    Brands segment performance REVENUE ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN USDm USDm 0.3 12 32 28 0.25 Kori launch cost All Kori expenses 10 excluded in included in 25 adj. EBITDA* adj. EBITDA* 23 0.2 8 20 15% 0.15 13% 12% 6 0.1 4 4 4 2 0.05 2 2% 2% 0 1 1 - Q2 2020 Q3 2020 Q4 2020 Q1 2021 Q2 2021

  15. Slide 15: Recent developments in Aker BioMarine

    Recent developments in Aker BioMarine Good progress and value creating activities … while we have experienced certain in important areas… setbacks in others ▪ Improved sales growth of Qrill Aqua ▪ Superba volume shortfall in South Korea 2021, impacting short term growth ▪ Important innovation develo

  16. Slide 16: 2021 outlook

    2021 outlook Offshore production Expected at 45-50 KT Onshore production The strong performance at Houston factory continues Revenue Modest revenue growth 1H 2021 vs. 2H 2021 Expects higher revenue and earnings in 2H 2021 than in 1H 2021 Adjusted EBITDA margin* Expected somewhat lower than last year

  17. Slide 17: Thank You

    Thank You ® AKER BIOMARINE

Aker BioMarine — DNB Nordic TMT & Consumer Conference 2021 on 6ix